These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 18708036

  • 1. Antinociceptive effects of intracerebroventricular administration of guanine-based purines in mice: evidences for the mechanism of action.
    Schmidt AP, Böhmer AE, Leke R, Schallenberger C, Antunes C, Pereira MS, Wofchuk ST, Elisabetsky E, Souza DO.
    Brain Res; 2008 Oct 09; 1234():50-8. PubMed ID: 18708036
    [Abstract] [Full Text] [Related]

  • 2. Spinal mechanisms of antinociceptive action caused by guanosine in mice.
    Schmidt AP, Böhmer AE, Schallenberger C, Antunes C, Pereira MS, Leke R, Wofchuk ST, Elisabetsky E, Souza DO.
    Eur J Pharmacol; 2009 Jun 24; 613(1-3):46-53. PubMed ID: 19379722
    [Abstract] [Full Text] [Related]

  • 3. Amnesic effect of GMP depends on its conversion to guanosine.
    Saute JA, da Silveira LE, Soares FA, Martini LH, Souza DO, Ganzella M.
    Neurobiol Learn Mem; 2006 May 24; 85(3):206-12. PubMed ID: 16325434
    [Abstract] [Full Text] [Related]

  • 4. Guanosine prevents thermal hyperalgesia in a rat model of peripheral mononeuropathy.
    Schmidt AP, Paniz L, Schallenberger C, Böhmer AE, Wofchuk ST, Elisabetsky E, Portela LV, Souza DO.
    J Pain; 2010 Feb 24; 11(2):131-41. PubMed ID: 19734104
    [Abstract] [Full Text] [Related]

  • 5. Systemic administration of GMP induces anxiolytic-like behavior in rats.
    Almeida RF, Cereser VH, Faraco RB, Böhmer AE, Souza DO, Ganzella M.
    Pharmacol Biochem Behav; 2010 Sep 24; 96(3):306-11. PubMed ID: 20566406
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice.
    Schmidt AP, Böhmer AE, Schallenberger C, Antunes C, Tavares RG, Wofchuk ST, Elisabetsky E, Souza DO.
    Br J Pharmacol; 2010 Mar 24; 159(6):1247-63. PubMed ID: 20132210
    [Abstract] [Full Text] [Related]

  • 7. Antinociceptive properties of the ethanolic extract and of the triterpene 3beta,6beta,16beta-trihidroxilup-20(29)-ene obtained from the flowers of Combretum leprosum in mice.
    Pietrovski EF, Rosa KA, Facundo VA, Rios K, Marques MC, Santos AR.
    Pharmacol Biochem Behav; 2006 Jan 24; 83(1):90-9. PubMed ID: 16458954
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antinociceptive properties of acetylenic thiophene and furan derivatives: evidence for the mechanism of action.
    Goncales CE, Araldi D, Panatieri RB, Rocha JB, Zeni G, Nogueira CW.
    Life Sci; 2005 Mar 25; 76(19):2221-34. PubMed ID: 15733937
    [Abstract] [Full Text] [Related]

  • 10. Role of adenosine receptors in the anti-nociceptive effects of allopurinol in mice.
    Essawy SS, Elbaz AA.
    Eur Rev Med Pharmacol Sci; 2013 Jul 25; 17(14):1857-63. PubMed ID: 23877847
    [Abstract] [Full Text] [Related]

  • 11. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E, Bagdas D, Gurun MS.
    Neurosci Lett; 2007 Jun 13; 420(2):116-21. PubMed ID: 17531379
    [Abstract] [Full Text] [Related]

  • 12. Antinociceptive and anti-allodynic effects of 3-alkynyl selenophene on different models of nociception in mice.
    Wilhelm EA, Jesse CR, Bortolatto CF, Nogueira CW, Savegnago L.
    Pharmacol Biochem Behav; 2009 Oct 13; 93(4):419-25. PubMed ID: 19538987
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
    Schmidt AP, Tort AB, Silveira PP, Böhmer AE, Hansel G, Knorr L, Schallenberger C, Dalmaz C, Elisabetsky E, Crestana RH, Lara DR, Souza DO.
    Pharmacol Biochem Behav; 2009 Feb 13; 91(4):549-53. PubMed ID: 18854198
    [Abstract] [Full Text] [Related]

  • 15. Effects of chronic administered guanosine on behavioral parameters and brain glutamate uptake in rats.
    Vinadé ER, Schmidt AP, Frizzo ME, Portela LV, Soares FA, Schwalm FD, Elisabetsky E, Izquierdo I, Souza DO.
    J Neurosci Res; 2009 Feb 13; 79(1-2):248-53. PubMed ID: 15558762
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropeptide S produces antinociceptive effects at the supraspinal level in mice.
    Li W, Chang M, Peng YL, Gao YH, Zhang JN, Han RW, Wang R.
    Regul Pept; 2009 Aug 07; 156(1-3):90-5. PubMed ID: 19345242
    [Abstract] [Full Text] [Related]

  • 18. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
    Goicoechea C, Sánchez E, Cano C, Jagerovic N, Martín MI.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):22-9. PubMed ID: 18706410
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dynorphin-mediated antinociceptive effects of L-arginine and SIN-1 (an NO donor) in mice.
    Chung E, Burke B, Bieber AJ, Doss JC, Ohgami Y, Quock RM.
    Brain Res Bull; 2006 Jul 31; 70(3):245-50. PubMed ID: 16861110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.